Published in J Am Coll Cardiol on December 09, 2005
New Biomarkers in Heart- and Renal Failure (IM19 Register) | NCT02830464
Biomonitoring and Cardiorenal Syndrome in Heart Failure(BIONICS-HF) Trial (BIONICS-HF) | NCT01570153
Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol (2007) 1.70
Natriuretic peptides in the diagnosis and management of heart failure. CMAJ (2006) 1.52
Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev (2007) 1.16
Emerging Roles of Natriuretic Peptides and their Receptors in Pathophysiology of Hypertension and Cardiovascular Regulation. J Am Soc Hypertens (2010) 1.05
Association of N-terminal pro-B-type natriuretic peptide with left ventricular structure and function in chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC]). Am J Cardiol (2012) 0.96
Urinary albumin excretion is associated with pulmonary hypertension in sickle cell disease: potential role of soluble fms-like tyrosine kinase-1. Eur J Haematol (2010) 0.96
Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol (2009) 0.87
Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patients. Crit Care (2009) 0.85
Relationship between obesity and N-terminal brain natriuretic Peptide level as a prognostic value after acute myocardial infarction. Korean Circ J (2010) 0.85
Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Fail Rev (2011) 0.83
Utility of traditional circulating and imaging-based cardiac biomarkers in patients with predialysis CKD. Clin J Am Soc Nephrol (2014) 0.82
The potential value of integrated natriuretic peptide and echo-guided heart failure management. Cardiovasc Ultrasound (2014) 0.82
Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C. Front Mol Neurosci (2014) 0.82
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence. Heart Fail Rev (2014) 0.82
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med (2014) 0.82
B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients. Pediatr Nephrol (2011) 0.81
Improving prognosis estimation in patients with heart failure and the cardiorenal syndrome. Int J Nephrol (2011) 0.81
B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function. BMC Nephrol (2013) 0.81
Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study. Am J Med (2014) 0.81
Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases. Heart Fail Rev (2010) 0.80
Recent advances in natriuretic peptide research. J Cell Mol Med (2008) 0.80
Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review. Heart Fail Rev (2006) 0.79
Combination of uric acid and NT-ProBNP: a more useful prognostic marker for short-term clinical outcomes in patients with acute heart failure. Korean J Intern Med (2010) 0.79
Serum glutathione S-transferase P1 1 in prediction of cardiac function. J Card Fail (2011) 0.78
NT-proBNP in cardiopulmonary resuscitated patients treated with mild therapeutic hypothermia is not independently associated with mortality: a retrospective observational study. BMC Anesthesiol (2015) 0.78
Pre-admission NT-proBNP improves diagnostic yield and risk stratification - the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study. Eur Heart J Acute Cardiovasc Care (2012) 0.78
Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients. Int J Endocrinol (2015) 0.78
Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis. JACC Heart Fail (2015) 0.77
Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography. J Am Heart Assoc (2015) 0.77
N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency. PLoS One (2014) 0.76
Amino-terminal pro-brain natriuretic peptide to diagnose congestive heart failure in patients with impaired kidney function. J Am Coll Cardiol (2006) 0.76
N-terminal pro-B-type natriuretic peptide and long-term mortality in non-ischaemic cardiomyopathy. Wien Klin Wochenschr (2011) 0.75
Supramaximal elevation in B-type natriuretic peptide and its N-terminal fragment levels in anephric patients with heart failure: a case series. J Med Case Rep (2012) 0.75
Validity of Amino Terminal pro-Brain Natiuretic Peptide in a Medically Complex Elderly Population. J Clin Med Res (2011) 0.75
Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease. J Vet Intern Med (2017) 0.75
Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency. J Korean Med Sci (2015) 0.75
Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome. Curr Cardiol Rev (2016) 0.75
Caveats in the interpretation of natriuretic peptide levels. Clinics (Sao Paulo) (2011) 0.75
C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations. PLoS One (2017) 0.75
The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology. Biomark Insights (2007) 0.75
Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine. Biomark Insights (2008) 0.75
Carfilzomib and the cardiorenal system in myeloma: an endothelial effect? Blood Cancer J (2016) 0.75
The NT-ProBNP Test in Subjects with End-Stage Renal Disease on Hemodialysis Presenting with Acute Dyspnea: Is Knowing Worth the Cost? Emerg Med Int (2013) 0.75
Biomarkers in predicting mortality and treatment in hemodialysis patients. F1000 Med Rep (2009) 0.75
Diagnosing and managing acute heart failure in the emergency department. Clin Exp Emerg Med (2015) 0.75
Brain natriuretic peptide as a potential novel marker of salt-sensitivity in chronic kidney disease patients without cardiac dysfunction. Heart Vessels (2016) 0.75
Biomarkers in heart failure: a clinical review. Heart Fail Rev (2008) 0.75
Comparative accuracy of NT-proBNP and MR-proANP for the diagnosis of acute heart failure in dyspnoeic patients. ESC Heart Fail (2017) 0.75
Managing Heart Failure at Home With Point-of-Care Diagnostics. IEEE J Transl Eng Health Med (2017) 0.75
Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence. Dis Markers (2017) 0.75
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation (2011) 14.00
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Third universal definition of myocardial infarction. J Am Coll Cardiol (2012) 8.59
Third universal definition of myocardial infarction. Circulation (2012) 8.47
Third universal definition of myocardial infarction. Eur Heart J (2012) 7.98
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Lifetime risks of cardiovascular disease. N Engl J Med (2012) 5.95
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation (2009) 4.87
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J (2005) 4.37
N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized multicenter IMPROVE-CHF study. Circulation (2007) 3.97
Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med (2007) 3.92
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol (2005) 3.85
Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation (2009) 3.50
Multiple behavior changes in diet and activity: a randomized controlled trial using mobile technology. Arch Intern Med (2012) 3.35
Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med (2007) 3.31
Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation (2005) 3.01
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics (2013) 2.80
Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med (2004) 2.74
Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol (2008) 2.74
Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging (2012) 2.72
Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. Prev Med (2008) 2.66
Anemia and mortality in heart failure patients a systematic review and meta-analysis. J Am Coll Cardiol (2008) 2.59
Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys. Circulation (2012) 2.59
Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease. Ann Emerg Med (2006) 2.57
Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation (2006) 2.56
Status of cardiovascular health in US adults: prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008. Circulation (2011) 2.54
Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA (2004) 2.45
Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation (2006) 2.40
Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation (2012) 2.40
Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol (2008) 2.36
Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol (2010) 2.34
Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol (2006) 2.29
Red blood cell distribution width and 1-year mortality in acute heart failure. Eur J Heart Fail (2009) 2.28
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. Eur Heart J (2008) 2.26
Gender-related differences in acute aortic dissection. Circulation (2004) 2.24
Systematic examination of the updated Framingham heart study general cardiovascular risk profile. Circulation (2009) 2.20
Improving the diagnosis of acute heart failure using a validated prediction model. J Am Coll Cardiol (2009) 2.18
Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes (2009) 2.17
Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol (2010) 2.06
Racial differences in risks for first cardiovascular events and noncardiovascular death: the Atherosclerosis Risk in Communities study, the Cardiovascular Health Study, and the Multi-Ethnic Study of Atherosclerosis. Circulation (2012) 1.99
Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. J Am Coll Cardiol (2011) 1.95
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation (2012) 1.95
Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure. Eur J Heart Fail (2010) 1.94
Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol (2011) 1.93
Predictive utility of pulse pressure and other blood pressure measures for cardiovascular outcomes. Hypertension (2007) 1.93
Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail (2011) 1.92
Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med (2004) 1.92
Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol (2007) 1.92
Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects. J Am Coll Cardiol (2009) 1.87
Ethnic differences in C-reactive protein concentrations. Clin Chem (2008) 1.87
Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J (2006) 1.81
Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J (2008) 1.75
Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation (2009) 1.74
Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem (2013) 1.71
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study. Int J Cardiol (2013) 1.69
Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J (2010) 1.68
Association of neighborhood characteristics with cardiovascular health in the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma--the Presage ST2 assay. Clin Chim Acta (2009) 1.65
Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience. Circ Arrhythm Electrophysiol (2014) 1.64
Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol (2005) 1.63
Noninvasive evaluation of coronary distensibility in older adults: a feasibility study with MR angiography. Radiology (2011) 1.60
Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Crit Care Med (2007) 1.59
Lifetime risk and years lived free of total cardiovascular disease. JAMA (2012) 1.57
Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. Eur Heart J (2012) 1.55
Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort. J Am Coll Cardiol (2013) 1.55
Emerging biomarkers in heart failure. Clin Chem (2011) 1.54
Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med (2004) 1.53
Yield of screening for coronary artery calcium in early middle-age adults based on the 10-year Framingham Risk Score: the CARDIA study. JACC Cardiovasc Imaging (2012) 1.52
Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome. Crit Care Med (2008) 1.52
Natural history of the early repolarization pattern in a biracial cohort: CARDIA (Coronary Artery Risk Development in Young Adults) Study. J Am Coll Cardiol (2013) 1.50
Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint. Prev Cardiol (2010) 1.49
Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus. JACC Cardiovasc Imaging (2009) 1.48
Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur Heart J (2012) 1.48
Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA (2007) 1.47
Be prepared--the Boston Marathon and mass-casualty events. N Engl J Med (2013) 1.47
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med (2014) 1.47
A propensity-matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age. Heart (2007) 1.46
Single resting hsTnT level predicts abnormal myocardial stress test in acute chest pain patients with normal initial standard troponin. JACC Cardiovasc Imaging (2013) 1.46
A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia. Heart Rhythm (2013) 1.46